Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
  • Columbia University Medical Center New York, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details
Completed

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

NCT00347412

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Northern Indiana Cancer Research Consortium South Bend, Indiana, United States
View all 75 locations
View Trial Details
Completed

A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

NCT03645330

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Akashi Medical Center Akashi, Japan
  • Hyogo Cancer Center Akashi, Japan
  • Akita University Hospital Akita, Japan
  • Hyogo Prefectural Amagasaki General Medical Center Amagasaki, Japan
View all 198 locations
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

NCT02071862

Conditions
Adenocarcinoma, Adenoma, Breast Diseases, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

NCT00966914

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham, Alabama, United States
  • Columbia, Missouri, United States
  • Philadelphia, Pennsylvania, United States
  • Germantown, Tennessee, United States
View all 42 locations
View Trial Details

Related conditions